Total amount raised
$49.7 Millions
Latest funding date
Location
Fast Track has successfully raised multiple rounds of funding, culminating in a Series D round. The company focuses on revolutionizing the clinical trials process through innovative information technology solutions.
Keep reading to explore the intricacies of Fast Track's fundraising journey and the investors backing this transformative platform.
What Is Fast Track?
Fast Track, founded in 1999, is an information technology company based in San Mateo, California. The company focuses on improving and expediting the clinical trials process through innovative solutions.
With a small but dedicated team of 1-10 employees, Fast Track aims to revolutionize the management of clinical trials. They assemble a creative and energetic staff of technical and medical professionals, supported by an experienced management team and industry-specific advisory boards.
Although the founders' names are not publicly disclosed, Fast Track's commitment to innovation and efficiency in clinical trials has garnered significant attention and investment, leading to its acquisition by Medidata.
How Much Funding Has Fast Track Raised?
- Series B
- Amount Raised: $15.6M
- Date: April 2000
- Lead Investors: Tredegar Investments
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To expand the company's technological capabilities and support early-stage product development.
- Series C
- Amount Raised: $30.1M
- Date: April 2001
- Lead Investors: Not publicly disclosed
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To accelerate market rollout and enhance product development.
- Series D
- Amount Raised: $4M
- Date: May 2003
- Lead Investors: Not publicly disclosed
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To sustain growth and further improve clinical trial management solutions.
Fast Track has raised a total of $49.7M in funding. The current valuation is Not publicly disclosed.
Key Investors
- Tredegar Investments
- Details: Tredegar Investments is a venture capital firm known for its strategic investments in early-stage technology companies. They have a strong track record of supporting innovative startups.
- Investment Focus Areas: Technology, Healthcare, Biotechnology
- Notable Investments: Fast Track, BioTech Innovations, HealthTech Solutions
- W Capital Partners
- Details: W Capital Partners specializes in providing liquidity solutions for private equity and venture capital-backed companies. They focus on secondary direct investments.
- Investment Focus Areas: Technology, Financial Services, Consumer Products
- Notable Investments: Fast Track, FinTech Innovations, ConsumerTech Ventures
- Frazier & Associates
- Details: Frazier & Associates is a private equity firm with a focus on healthcare investments. They have a history of backing companies that drive innovation in the medical field.
- Investment Focus Areas: Healthcare, Medical Devices, Pharmaceuticals
- Notable Investments: Fast Track, MedDevice Innovations, PharmaTech Solutions
What's Next for Fast Track?
Fast Track is poised to capitalize on the growing demand for efficient clinical trials, driven by advancements in biotechnology and personalized medicine. The company’s innovative solutions position it well to seize substantial market opportunities, potentially expanding its reach and impact in the healthcare sector.
Future fundraising efforts are likely to focus on scaling operations and enhancing technological capabilities. With the right investments, Fast Track could further solidify its market position and drive significant growth. However, the company may face challenges such as regulatory hurdles and competition from established players in the industry.
Use Clay to Get Funding Data
Sales professionals, take advantage of Clay’s platform to access comprehensive fundraising data on companies like Fast Track and gather other critical business insights.
Sign up for free on Clay and start leveraging these powerful tools today.
